Those figures compared with a loss of $10 million and an operating margin of -1 percent in the same period in 2022.
The results for the nine months ending May 31 were not as positive as the nine-hospital system reported a $35.1 million operating loss for the period as expenses rose almost 6.6 percent. That loss compares with operating income of $56.8 million in the same period in 2022.
Revenues rose slightly in the nine-month period to total $3.1 billion, but salaries and benefits rose 2.7 percent and supply expenses increased 12.5 percent compared with the same period ending May 31, 2022. The operating margin declined from 1.9 percent to -1.1 percent.
Contract labor expenses for the nine-month period were down $10.4 million, with such expenses at their lowest as of May 31 since Nov. 30, 2021.
Net income totaled $43.8 million for the second quarter and $21.7 million for the nine months.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
